Biogen (market cap: US$22B) share price performed well since it's bottomed out last month.
- Biogen: net debt ~US$3.9B due to the acquisition of Reata for US$7.3B;
In 2024, Biogen generated net cash flow from operating activities of US$2.9B, less Capex US$154m, annual net cash flow: US$2.75B
Currently NEU market cap: A$1.58B (US$0.998B) with net cash ~A$355m, enterprise value is only US$0.77B
Biogen (market cap: US$22B) share price performed well since...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.03 |
Change
0.720(5.41%) |
Mkt cap ! $1.730B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.09 | $12.96 | $4.947M | 361.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 318 | $14.03 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.04 | 21 | 1 |
View Market Depth
| Last trade - 12.43pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |